Cite
HARVARD Citation
Yu, L. et al. (2014). Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model. International journal of gynecological cancer. 24 (7), pp. 1158-1164. [Online].